Clinical spectrum of niemann-pick disease type C

Neurology

Volumn 39, Issue 8, 1989, Pages 1040-1049

  Fink, J K ^a   Filling Katz, M R ^a   Sokol, J ^a   Cogan, D G ^c   Pikus, A ^b   Sonies, B ^d   Soong, B ^e   Pentchev, P G ^a   Comly, M E ^a   Brady, R O ^a   Barton, N W ^a  

^a MSC 1260   (United States)

^b Office of the Director   (United States)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

^e TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; CHILD; CLINICAL ARTICLE; DEMENTIA; DYSPHAGIA; EXTRAPYRAMIDAL SYNDROME; FEMALE; HEREDITY; HUMAN; MALE; NIEMANN PICK DISEASE TYPE C; PRIORITY JOURNAL; SEIZURE;

ADOLESCENT; ADULT; AGE FACTORS; CASE REPORT; CHILD; CHILD, PRESCHOOL; COMPARATIVE STUDY; ELECTROENCEPHALOGRAPHY; FEMALE; HUMAN; INFANT; MALE; NIEMANN-PICK DISEASES; PHENOTYPE;

EID: 0024459132     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/wnl.39.8.1040     Document Type: Article

References (61)

1. Crocker AC, Farber S. Niemann-Pick disease: a review of eighteen patienta. Medicine 1958;37:1–95.
2. Crocker AC. The cerebral defect in Tay-Sachs disease and Niemann-Pick disease.J Neurochem 1961;7:69–80.
3. Elleder M, Jirasek A. Niemann-Pick disease. Universitatis Carolinae Medica 1983;29:259–267.
4. Brady RO. Sphingomyelin lipidosis: Niemann-Pick disease. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, eds. The metabolic basis of inherited disease, 4th ed. New York McGraw-Hill, 1978:718–730.
5. Karpati G, Carpenter S, Wolfe LS, Andermann F. Juvenile dystonic lipidosis: an unusual form of neurovisceral storage disease. Neurology 1977;27:37–42.
6. Norman RM, Forrester RM, Tingey AH. The juvenile form of Niemann-Pick disease. Arch Dis Child 1967;42:91–97.
7. Wenger DA, Barth G, Githens JH. Nine cases of sphingomyelin lipidosis: a new variant in Spanish-American children. Am J Dis Child 1977;131:955–961.
8. Yan-Go FL, Yanagihara T, Pierre RV, Goldstein NP. A progressive neurologic dieorder with supranuclear vertical gaze paresis and distinctive bone marrow cells. Mayo Clin Proc 1984;59:404–410.
9. Breen L, Morris H, Alperin JB, Schochet SS. Juvenile Niemann-Pick disease with vertical supranuclear ophthalmoplegia: two case reports and review of the literature. Arch Neurol 1981;38:388–390.
10. Neville BGR, Lake BD, Stephens R, Sanders MD. A neurovisceral storage disease with vertical supranuclear ophthalmoplegia, and its relationship to Niemann-Pick disease: a report of nine patients. Brain 1973;96:97–120.
11. Jaeken J, Proesmans W, Eggermont E. Niemann-Pick type C disease and early cholestasis in three brothers. Acta Paediatr Belg 1980;33:43–46.
12. Yatziv S, Leibovitz-Ben G, Ornoy A, Bach G. Clinical heterogeneity in a sibship with Niemann-Pick disease type C. J Genet 1983;23:125–131.
13. Guibaud P, Vanier MT, Malpuech G, et al. Forme infantile précoce, cholestatique, rapidement mortelle, de la sphingomyelinose type C: à propos d’2 observations. Pediatrie 1979;43:103–114.
14. Bury F, Jaeken J, Eggermont E, et al. Choloetase d’apparition précoce dans la maladie de Niemann-Pick à propos d’un cas de type C. J Pediatrie 1979;4:351–357.
15. Elleder M, Jirasek A, Vlk J. Adult neurovisceral lipidosis compatible with Niemann-Pick disease tvpe C. Virchows Arch [A] 1983;401:35–43.
16. Longstreth T, Daven JR, Farrell DF, Bolen JW, Bird TD. Adult dvstonic lipidosis: clinical, histoloaic, and biochemical findines of a neurovisceral storage disease. Neurology 1982;32:1295–1299.
17. Pentchev PG, Comly ME, Kruth HS, et al. A defect in cholesterol esterification in Niemann-Pick disease (type C) patienta. Proc Natl Acad Sci USA 1985;82:8247–8251.
18. Pentchev PG, Kruth HS, Comly ME, Butler JD, Vanier MT, Wenger DA. Type C Niemann-Pick disease: a parallel lose of regulatory responses in both the uptake and eaterification of low-density lipoprotein-derived cholesterol in cultured fibroblasts. J Biol Chem 1986;251:16775–16780.
19. Cogan DG, Chu FC, Bachman DM, Barranger J. The DAF syndrome. Neuroophthalmol 1981;2:7–16.
20. Adams RD, Lyon G. The lysosomal storage disease. In: Adams RD, Lyon G, eds. Neurology of hereditary metabolic diseases of children. Washington, DC Hemisphere Publishing, 1962:55–58.
21. Elleder M, Cihula J. Niemann-Pick disease (variation in the sphingomyelinase deficient group): neurovisceral phenotype (A) with abnormally protracted clinical course and variable expression of neurologic symptomatology in three siblings. Eur J Pediatr 1983;140:323–328.
22. Schneider ED, Pentchev PG, Hibbert SR, Sawitsky A, Brady RO. A new form of Niemann-Pick disease characterized by temperature-labile sphingomyelinase. J Med Genet 1978;15:370–374.
23. Kandt RS, Emerson RG, Singer HS, Valle DL, Moser HW. Cataplexy in variant forms of Niemann-Pick disease. Ann Neurol 1982;12:284–288.
24. Philippart M, Engel J, Zimmerman EG. Gelastic cataplexy in Niemann-Pick group C and related varianta without generalized sphingomyelinase deficiency. Ann Neurol 1983;14:492–493.
25. Pikus AT. Audiologic profile in several metabolic disorders. Abstracte of 19th International Congress of Audiology, June 1988:20.
26. Grover WD, Naiman JL. Progreasive paresis of vertical gaze in lipid storage disease. Neurology 1971;21:896–899.
27. Ivemark BI, Svennerholm L, Thoren C, Tunell R. Niemann-Pick disease in infancy: report of two siblings with clinical, histologic, and chemical studies. Acta Paediatr 1963;52:391–404.
28. Ashkenazi A, Yarom G, Gutman A, Abrahamov A, Russell A. Niemann-Pick disease and giant cell transformation of the liver. Acta Paediatr Scand 1971;60:285–294.
29. Mitchell ML, Erickson RP, Schmid D. Hieber V, Poznanski AK, Hicks SP. Mannosidosis: two brothers with different degrees of disease severity. Clin Genet 1981;20:191–202.
30. Wengar DA, Roth S, Sattler M. Acute neuronopathic (infantile) and chronic nonneuronopathic (adult) Gaucher disease in full siblings. J Pediatr 1982;100:252–254.
31. Deleon GA, Kaback MM, Elfenbein IB, Percy AK, Brady RO. Juvenile dystonic lipidosis. Johns Hopkine Med J 1969;125:62–77.
32. Elfenbein IB. Dystonic juvenile idiocy without amaurosis a new syndrome. Light and electron microscopic observations of cerebrum. Johns Hopkins Med J 1968;123:205–221.
33. Pons G, Ponsot G, Leveque B, Lyon G. Maladie de surcharge neuroviscérale avec ophtalmoplégie supra-nucléaire de la verticalité et presence dans la moelle d’hietiocytes bleutes ou maladie de Neville: à propos de 2 observations. Ann Pediatr (Paris) 1976;23:503–508.
34. Witdeben CL, Palmieri MJ, Watkins JB, Hogan P. Sphingomyelin lipidoais variant with cirrhosis in the pediatric age group. Arch Pathol Lab Med 1986;110:508–512.
35. Cogan DG, Chu FC, Reingold D, Bananger J. Ocular motor signs in some metabolic diseases. Arch Ophthalmol 1981;99:1802–1808.
36. Zee DS, Optican LM, Cook JD, et al. Slow saccadea in epinocerebellar degeneration. Arch Neurol 1976;33:242–251.
37. Koeppen AH, Hana MB. Supranuclear ophthalmoplegia in olivopontocerebellar degeneration. Neurology 1976;26:764–768.
38. Chu FC, Reingold DB, Cogan DC, Williams AC. The eye movement disordere of progreseive supranuclear palsy. Ophthalmology 1979;86:422–428.
39. Dacremont G. Niemann-Pick disease. N Engl J Med 1973;289:592–593.
40. Chriatomanou H. Niemann-Pick disease type C: evidence for the deficiency of an activating factor stimulating ephingomyelin and glucocerebroside degradation. Hoppe Seylere Z Physiol Chem 1980;361:1489–1502.
41. Elleder M, Smid F, Hyniova H, Cihula J, Zeman J, Macek M. Liver findings in Niemann-Pick dieeaee type C. Histochem J 1984;16:1147–1170.
42. Elleder M, Jirasek A, Smid F, Ledvinova J, Besley GTN, Stopekova M. Niemann-Pick disease type C with enhanced glycolipid storage: report on further cdee of so-called lactosylceramidoeis. Virchows Arch [A] 1984;402:307–317.
43. Elleder M, Jirasek A, Ledinova J, Besley GTN. Niemann-Pick disease type C: study on the nature of the cerebral storage process. Acta Neuropathol (Berl) 1985;66:325–336.
44. Philippart M, Martin L, Martin JJ, Menkes H. Niemann-Pick dirrease: morphologic and biochemical studies in the visceral form with late central nervous system involvement (Crocker’s group C). Arch Neurol 1963;20:227–238.
45. Vanier MT. Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. Biochern Biophye Acta 1983;750:278–284.
46. Harder A, Widjaja F, Debuch H. Studies on lipids from liver and spleen of a child (O.L.) with Niemann-Pick’s disease type C. J Clin Chem Cli Biochem 1984;22:199–201.
47. Vanier MT, Roueson R. Niemann-Pick dieeaee: a clinical and biochemical study. In: Vankr MT, ed. Recent progress in neurolipidosee and allied disorders. Lyon, France: Collection Fondation Merieux, 1984:183–201.
48. Callahan JW, Khnlil M, Gerrie J. Isoenzymea of sphingomyelinase and the genetic defect in Niemeum-Pick disease, type C. Biochem Biophys Ree Commun 1974;58:384–390.
49. Bealey GTN. Sphingomyelinase defect in Niemann-Pick disease type C fibroblasts. FEBS Lett 1977;80:71–74.
50. Fujibayaehi S, Wenger DA. Studies on a sphingolipid activator protein (SAP-2) in fibroblasts from patients with lyeosomal storage diseasee, including Niemann-Pick disease type C. Clin Chim Acta 1985;146:147–156.
51. Vanier MT, Roueson R, Louieot P. Chromatofocueing of akin fibroblast sphingomyelinase: alterations in Niemann-Pick disease type C shared by CM-gangliosidosis. Clin Chim Acta 1983;130:155–161.
52. Vanier MT, Roueson R, Garcia I, et al. Biochemical studies in Niemann-Pick disease III: in vitro and in vivo assays of sphingomyelin degradation in cultured skin fibroblasts and amniotic fluid cells for the diagnosis of various forms of the diaease. Clin Genet 1985;27:20–32.
53. Maziere JC, Maziere C, Mora L, Routier JD, Polonovski J. In situ degradation of sphingomyelin by cultured normal fibroblasts and fibroblasts from patients with Niemann-Pick disease type A and C. Biochem Biophye Res Commun 1982;108:1101–1106.
54. Kudoh T, Vellroff M, Wenger DA. Uptake and metabolism of radioactively labeled sphingomyelin in cultured Bkin fibroblaete from controls and patients with Niemann-Pick dieeaee and other lysommal storage dieeasea. Biochem Biophya Acta 1983;754:82–92.
55. Nakanhima M, Kudoh T, Sukegawa K, Maruyama K, Orii T. Metabolism of ephingomyelin in cultured skin fibroblasts from patients with Merent typea of Niemann-Pick dieease. Tohoku J EIP Med 1986;148:365–371.
56. Vanier MT, Revol A, Fichet M. Sphingomyelinaae activities of various human tiesuee in control subjects and in Niemann-Pick dieeaae: development and evaluation of a microprocedure. Clin Chim Ada 1980;106:257–267.
57. Philippart M, Gautier M, Gatti R, Durand P, Vamoe-Hurwitz E. Sphingomyelin metabolism in the Niemann-Pick syndrome. Proc Int Soc Neurochem 1977;6:417.
58. Pouloe A, Hudson N, Ranieri E. Sphingomyelinaee in cultured akin fibroblasts from normal and Niemann-Pick type C patients. Clin Genet 1983;24:225–233.
59. Butler JD, Comly ME, Kruth HS, et al. Niemann-Pick varinnt disorders: comparieon of errors of cellular cholesterol homeoetaeie in pup D and group C fibroblasts. Proc Natl Acad Sci USA 1987;84:556–660.
60. Kruth HS, Comly ME, Butler JD, et al. Type C Niemann-Pick dieeaae: abnormal metabolism of low-density lipoprotein in homozygous and heterozygous fibroblasts. J Biol Chem 1986;261:16769–16774.
61. Maziere JC, Maziere C, Gardette J, Mora L. Polonovski J. Chnngea in choleaterol metabolism in cultured fibroblasts from patients with Niemann-Pick disease. Biochem Biophys Res Commun 1981;102:113–118.